Further analyses of CML bone marrow samples revealed that the percentage of CD68+, CD163+, and CD206+ macrophages in BM samples of CML patients was significantly higher than in the control group and was gradually elevated during the progression of CML from chronic phase to blast crisis. This evidence concerns the gene CD163 and chronic myelogenous leukemia, BCR-ABL1 positive.